Literature DB >> 2947743

Is vasospasm related to platelet deposition? Relationship in a porcine preparation of arterial injury in vivo.

J Y Lam, J H Chesebro, P M Steele, L Badimon, V Fuster.   

Abstract

Although aggregating platelets can release potent vasoactive substances in vitro, the importance of platelets in mediating naturally occurring or provoked spasm in vivo is not clear. To investigate the possible role of platelets in arterial spasm following arterial injury induced by angioplasty, quantitative platelet deposition of the dilated arterial segment and the degree of vasoconstriction (average percent diameter narrowing just proximal and distal to the dilated segment) produced during angioplasty of the common carotid arteries were studied in 42 heparinized normal pigs that were killed immediately after the angioplasty procedure. Angiographic films of the carotid arteries were taken before and after the dilatation to assess the vasoconstriction. Vasoconstriction was greater (40% vs 19%, p less than .002) when platelet deposition (X 10(6)/cm2) was in excess of 10, and the severity of vasoconstriction in vivo had a close positive exponential correlation (r = .77, p less than .001) with extent of platelet deposition in 24 untreated pigs. Platelet deposition and vasoconstriction were greater with severe arterial wall injury than with mild injury (58.8 versus 6.9, p less than .0001; 37% vs 21%, p less than .001, respectively). After severe injury in 18 pigs pretreated with 1 mg/kg/day aspirin, platelet deposition decreased (from 58.8 to 19.6, p less than .02) and vasoconstriction decreased (from 37% to 21%, p less than .003) relative to control. After mild injury, platelet deposition and vasoconstriction were mild and unchanged by aspirin. Thus, local vasoconstriction is influenced by the degree of platelet deposition.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2947743     DOI: 10.1161/01.cir.75.1.243

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  19 in total

1.  [The experimental investigation on the preventive effects of API0134 against the re-occlusion of coronary arteries after therapeutic thrombolysis in dogs].

Authors:  S Li; H Zhao; Z Guo
Journal:  J Tongji Med Univ       Date:  1999

Review 2.  Advances in thrombolytic therapy.

Authors:  M Verstraete
Journal:  Cardiovasc Drugs Ther       Date:  1992-04       Impact factor: 3.727

Review 3.  Vessel wall-related risk factors in acute vascular events.

Authors:  L Badimon; J J Badimon; M Cohen; J H Chesebro; V Fuster
Journal:  Drugs       Date:  1991       Impact factor: 9.546

4.  Intimal injury in a transiently occluded coronary artery increases myocardial necrosis. Effect of aspirin.

Authors:  J A Barrabés; D Garcia-Dorado; J Oliveras; M A González; M Ruiz-Meana; J Solares; A G Burillo; R M Lidón; M Antolín; J Castell; J Soler-Soler
Journal:  Pflugers Arch       Date:  1996-08       Impact factor: 3.657

5.  [Relation between post-thrombotic syndrome, ADP-induced thrombocyte aggregation and intrathrombocyte calcium content].

Authors:  B Heintz; C Femers; N Maurin; H Kierdorf; C Brilon; V Wienert
Journal:  Klin Wochenschr       Date:  1989-12-04

6.  Morphology of the endothelium over atherosclerotic plaques in human coronary arteries.

Authors:  M J Davies; N Woolf; P M Rowles; J Pepper
Journal:  Br Heart J       Date:  1988-12

7.  High frequency rotational ablation: an alternative in treating coronary artery stenoses and occlusions.

Authors:  U Dietz; R Erbel; H J Rupprecht; S Weidmann; J Meyer
Journal:  Br Heart J       Date:  1993-10

8.  Raised concentrations of macrophage colony stimulating factor in severe unstable angina beyond the acute phase are strongly predictive of long term outcome.

Authors:  L S Rallidis; M G Zolindaki; P C Pentzeridis; K P Poulopoulos; A H Velissaridou; T S Apostolou
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

Review 9.  Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris.

Authors:  J Frampton; M M Buckley; A Fitton
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546

Review 10.  The high-risk unstable angina patient. An approach to treatment.

Authors:  S Kar; Y Wakida; R Nordlander
Journal:  Drugs       Date:  1992-06       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.